FDA — authorised 27 February 2020
- Application: NDA212728
- Marketing authorisation holder: PFIZER
- Local brand name: NURTEC ODT
- Indication: TABLET, ORALLY DISINTEGRATING — ORAL
- Status: approved
🇺🇸 Nurtec Odt in United States
FDA authorised Nurtec Odt on 27 February 2020
Marketing authorisations
FDA
- Application: ANDA219399
- Marketing authorisation holder: APOTEX CORP
- Local brand name: RIMEGEPANT
- Indication: TABLET, ORALLY DISINTEGRATING — ORAL
- Status: approved
Nurtec Odt in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Nurtec Odt approved in United States?
Yes. FDA authorised it on 27 February 2020; FDA has authorised it.
Who is the marketing authorisation holder for Nurtec Odt in United States?
PFIZER holds the US marketing authorisation.